---
title: GBM66 GBM Model - TD2 Precision Oncology
description: Study brain cancer with the GBM66 patient-derived xenograft - a powerful research tool for in vivo glioblastoma studies.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/gbm66.png
---
×
[](https://td2inc.com/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
# GBM66 GBM Model
GBM66, a Patient-Derived Xenograft (PDX) model, offers a unique perspective on brain cancer. Utilize this model to unravel disease mechanisms and discover innovative treatment options. PDX models like GBM66 play a pivotal role in preclinical drug discovery, enabling researchers to assess potential drug candidates in a controlled environment. GBM66 closely replicates the patient’s tumor, offering valuable insights into treatment efficacy and safety. By using GBM66, you can accelerate the development of targeted therapies for brain cancer, benefiting patients worldwide.
## Model Details
**Cancer Location:** Intracranial
**Cancer Type:** Brain Cancer
**Model Name:** GBM66
**Mouse Strain:** Nu/Nu
**WES:** Yes
**Methylation:** Yes
**Patient Treatment History:** Yes
## GBM66 Survival
Survival of orthotopic intracranial implanted GBM66 in Nu/Nu mice (n=11)
### Request Additional GBM Model Data
## CONTACT US
## Get Started.
Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.
[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
Office
13208 E. Shea Blvd,
Suite 100
Scottsdale, AZ 85259
Phone
(602) 358-8300
Connect with us
-
-
© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)